KORU Medical Systems, Inc. (KRMD)

Market Cap	184.27M
Revenue (ttm)	31.99M
Net Income (ttm)	-11.97M
Shares Out	45.84M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	209,200
Open	3.690
Previous Close	3.700
Day's Range	3.610 - 4.030
52-Week Range	1.978 - 4.600
Beta	0.44
Analysts	Strong Buy
Price Target	4.13 (+2.74%)
Earnings Date	Nov 13, 2024

About KRMD

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The comp...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 82
• Stock Exchange: NASDAQ
• Ticker Symbol: KRMD
• Website: https://www.korumedical.com

Financial Performance

In 2023, KORU Medical Systems's revenue was $28.52 million, an increase of 2.23% compared to the previous year's $27.90 million. Losses were -$13.74 million, 58.7% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price forecast is $4.13, which is an increase of 2.74% from the latest price.

Price Target

$4.13

(2.74% upside)

Analyst Consensus: Strong Buy